About Index Trending news
Analyze
Pricing
Versant Ventures

Versant Ventures

Work at Versant Ventures? Add yourself to this profile

Versant Ventures

Versant Ventures is a leading global healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies.

Elsewhere

Alexa global traffic share

22 Jun 2017
$68,000,000
Venture capital (Series A)

Quebec's Repare Therapeutics raises $68M in Series A funding

Fundnews
+1
01 Jun 2017
$26,600,000
Venture capital (Series C)

Monteris raises $26.6 mln in Versant, SightLine-led Series C

PE Hub
+2
02 Feb 2017
$30,000,000
Venture capital (Series D)

Tarveda Therapeutics Raises $30M in Series D Financing

FinSMEs
+1
21 Dec 2016

Venture Capital Access Online | Venture Capital News

vcaonline
+1
12 Dec 2016
$225,000,000
Venture capital (Series A)
Versant Ventures, Bayer AG

Regenerative Medicine Company BlueRock Therapeutics Raises $225M in Series A Funding

FinSMEs
+2
10 Nov 2016

Venture Capital Access Online | Venture Capital News

vcaonline
+1
02 Nov 2016
$30,895,100
Venture capital (Series B)
Versant Ventures, OrbiMed, F-Prime Capital Partners, +1

Biotech Firm Raises $41 Million to Advance Cancer-Fighting Technologies

Techvibes
+1
17 May 2016
€12,000,000
Venture capital (Series A)
Versant Ventures, LSP BioVentures

Nouscom Closes €12M in Series A Funding

FinSMEs
09 Mar 2016
€46,000,000
Venture capital (Series B)

Aprea AB: Cancer Company Aprea Closes EUR 46 Million (~USD 51 Million) Series B Financing

businesswire
+2
30 Jun 2015
$12,400,000
Venture capital (Series B)
Added by

FinSMEs | Inari Medical Closes $12.4M Series B Financing

FinSMEs